Protea Biosciences (West Virginia) Concludes New Technology License Agreement (9/8/2010)

Protea Biosciences is a West Virginia University spinoff that develops microfluidics and cell signaling technology for protein research.

Protea Biosciences, a leading developer of new bioanalytical technology, announced today that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules. In an article published yesterday in the prominent journal PLoS ONE, a team of researchers at George Washington University led by Akos Vertes, PhD., used the newly‐developed LAESI technology to rapidly identify virally-°©‐infected human cells. [read more]

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: